Startup profile for QunaSys: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

QunaSys funding, valuation and investors

Japanese quantum algorithms and software company focused on chemistry and industrial research.

Verified company research · funding, investors and latest developments

Keep track of QunaSys

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B2

JPY1.7B equity; excludes separate JPY500M credit line · November 1, 2024

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$10M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · Tokyo, Japan

Investors in latest funding

Lead: Mirai Creation Fund III (SPARX Asset Management)

Other: JIC Venture Growth Investments / VGF I , Fujitsu Ventures Fund , ME Innovation Fund (Mitsubishi Electric / Global Brain) , OUVC No.2 Fund , KDDI Open Innovation Fund III , KVIF-I (Kyocera / Global Brain) , Zeon Corporation

Sources: latest funding · qunasys.com Last verified: 2026-10-26

Overview

QunaSys develops quantum algorithms and software for chemistry, materials research and hybrid quantum-classical workflows. Its disclosed financing includes a $10 million Series B in March 2022 and JPY1.7 billion Series B2 in November 2024. The later round was led by the SPARX-managed Mirai Creation Fund III.

A separately announced JPY500 million bank credit line is borrowing capacity, not additional equity or proof the full facility was drawn. Industrial research collaborations and software partnerships should be evaluated separately from share ownership; some partners are investors, but a partnership alone does not establish that relationship.

Why QunaSys is interesting

Its investor syndicate links quantum software to industrial users, while its equity financing and separate bank credit facility provide a useful funding comparison.

Key facts

  • November 2024 source separately identifies a JPY500M Sumitomo Mitsui Banking Corporation credit line; no drawdown amount is established.
  • IBM Ventures is described as an existing investor in the release's commentary, not automatically assigned to the new Series B2 syndicate.

Funding history (newest first)

Series B2

2024-11-01 JPY1.7B equity; excludes separate JPY500M credit line
  • Mirai Creation Fund III (SPARX Asset Management) (lead)
  • JIC Venture Growth Investments / VGF I (participant)
  • Fujitsu Ventures Fund (participant)
  • ME Innovation Fund (Mitsubishi Electric / Global Brain) (participant)
  • OUVC No.2 Fund (participant)
  • KDDI Open Innovation Fund III (participant)
  • KVIF-I (Kyocera / Global Brain) (participant)
  • Zeon Corporation (participant)

Source: Read source · qunasys.com

Series B

2022-03-28 $10M
  • JIC Venture Growth Investments (lead)
  • ANRI (participant)
  • Fujitsu Ventures Fund (participant)
  • Global Brain (participant)
  • HPC Systems (participant)
  • JST SUCCESS Program (participant)
  • MUFJ Capital (name as printed in release) (participant)
  • Shinsei Corporate Investment (participant)
  • Zeon Corporation (participant)

Source: Read source · qunasys.com

Investors in our directory

Funds linked from QunaSys's profile — open a fund page for stage focus and related deal articles.

Industries

Market / IPO context

Editorial / static context — not a live quote.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.